Enzyme replacement therapy (ERT) is the current standard treatment for Pompe disease, a lysosomal storage disorder caused by deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA). The gene discussed is GAA; the disease is Glycogen storage disease due to acid maltase deficiency.